Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, Casgevy treats sickle cell disease and beta-thalassaemia by editing patients' blood stem cells to produce functional haemoglobin. Clinical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ZUG, Switzerland and BOSTON - CRISPR Therapeutics (NASDAQ:CRSP), a pioneer in gene-based medicine, has announced that Chief Operating Officer Julianne Bruno is set to leave the company on April 11, ...

Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

John Greene, a director at CRISPR Therapeutics AG (NASDAQ:CRSP), made a significant acquisition of the company's stock, according ...

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...